Resistance to immune checkpoint inhibitors and the tumor microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resistance to immune checkpoint inhibitors and the tumor microenvironment

Published:2022-12-08 Issue:3 Volume:32 Page:240-249
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Experimental Dermatology

Author:

Kawashima Shusuke¹²,Togashi Yosuke²³^ORCID

Affiliation:

1. Department of Dermatology, Graduate School of Medicine Chiba University Chiba Japan

2. Chiba Cancer Center Research Institute Chiba Japan

3. Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan

Funder

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14716

Reference117 articles.

1. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

2. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

3. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

4. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

5. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in nanomedicine for sonodynamic immunotherapy of tumors;EngMedicine;2024-09

2. Lipid-based nanosystems: the next generation of cancer immune therapy;Journal of Hematology & Oncology;2024-07-19

3. Shifting cold to hot tumors by nanoparticle-loaded drugs and products;Clinical and Translational Oncology;2024-06-26

4. Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors;Molecular Pharmaceutics;2024-06-05

5. Machine learning–based integration develops a stress response stated T cell (Tstr)–related score for predicting outcomes in clear cell renal cell carcinoma;International Immunopharmacology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3